Rebecca Taub
Founder bij MADRIGAL PHARMACEUTICALS, INC.
Vermogen: 298 M $ op 31-03-2024
Profiel
Rebecca A.
Taub was the founder of Madrigal Pharmaceuticals, Inc. (founded in 2011) where she held the title of Chief Executive Officer in 2011.
She is also the founder of Madrigal Pharmaceuticals, Inc. (founded in 2016) where she currently holds the title of Director, President-Research & Development.
Dr. Taub's current job is as an Independent Director at BriaCell Therapeutics Corp.
(since 2018).
Her former jobs include Executive Director-CNS & Obesity Research at Bristol Myers Squibb Co. (2000-2003) and DuPont Pharmaceuticals Co. (2000-2003), Vice President-Research at Roche Pharmaceuticals, Inc., Professor at the University of Pennsylvania (1987-2002), Vice President-Research & Metabolic Diseases at Hoffmann-La Roche, Inc. (2004-2007), Associate Investigator at Howard Hughes Medical Institute, Inc., Senior Vice President-Research & Development at VIA Pharmaceuticals, Inc. (2008-2011), Assistant Professor at Harvard Medical School, and Professor at Perelman School of Medicine (1997-2001).
Dr. Taub's education includes a doctorate from Yale School of Medicine and an undergraduate degree from Yale College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-04-2024 | 1 114 539 ( 5.60% ) | 298 M $ | 31-03-2024 | |
| 20-12-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Rebecca Taub
| Bedrijven | Functie | Begin |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Founder | 01-07-2016 |
| BRIACELL THERAPEUTICS CORP. | Director/Board Member | 07-03-2018 |
Eerdere bekende functies van Rebecca Taub
| Bedrijven | Functie | Einde |
|---|---|---|
| VIA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2011 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Chief Tech/Sci/R&D Officer | 01-01-2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2003 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01-01-2003 |
| University of Pennsylvania | Corporate Officer/Principal | 01-01-2002 |
Opleiding van Rebecca Taub
| Yale School of Medicine | Doctorate Degree |
| Yale College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| VIA PHARMACEUTICALS, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Madrigal Pharmaceuticals, Inc. develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. It specializes in the treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis, diabetes, dyslipidemia, and cardiovascular disease. The company was founded by Rebecca A. Taub, Brian N. Cunningham, and Edward Chiang in September 2011 and is headquartered in Fort Washington, PA. | Health Technology |
